Benkeser, David

Assessing differential impacts of COVID-19 on black communities

Millett, G. A., Jones, A. T., Benkeser, D., Baral, S., Mercer, L., Beyrer, C., Honermann, B., Lankiewicz, E., Mena, L., Crowley, J. S., et al. (2020) · Annals of Epidemiology

COVID-19 epidemiological studiesHealth disparities and outcomes

Cited by 1,217

Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial

Gilbert, P. B., Montefiori, D. C., McDermott, A. B., Fong, Y., Benkeser, D., Deng, W., Zhou, H., Houchens, C. R., Martins, K., Jayashankar, L., et al. (2022) · Science

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 1,137

Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine

Falsey, A. R., Sobieszczyk, M. E., Hirsch, I., Sproule, S., Robb, M. L., Corey, L., Neuzil, K. M., Hahn, W., Hunt, J., Mulligan, M. J., et al. (2021) · New England Journal of Medicine

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 670

Hepatitis C care cascade among patients with and without tuberculosis: Nationwide observational cohort study in the country of Georgia, 2015–2020

Baliashvili, D., Blumberg, H. M., Gandhi, N. R., Averhoff, F., Benkeser, D., Shadaker, S., Gvinjilia, L., Turdziladze, A., Tukvadze, N., Chincharauli, M., et al. (2023) · PLOS Medicine

Hepatitis C virus researchTuberculosis Research and Epidemiology

Cited by 0